In the afternoon, Chairman Wang Yuan and his party, accompanied by Chairman Li Lelin and the company’s senior management, visited the GMP standard workshop and R&D center of Huaxin Biotech. Chairman Wang Yuan recognized Huaxin Biotech’s international advanced equipment and expressed The large investment in research and development is highly appreciated.

Afterwards, the two parties came to the meeting room to have in-depth discussions on deepening cooperation and achieving a win-win development direction. At the meeting, Chairman Wang Yuan said: Shenji Ointment is an OTC (National Medicine Standard B20020541) product of Wanze Pharmaceutical and has a national invention. Patent, it has significant effect on removing chloasma and improving complexion. You must choose a company with strict product quality control, mature production technology, and perfect sales team for cooperation and transformation. Huaxin Bio is just such a mature skin care product. R&D, production and sales enterprises, this will also be an important part of the in-depth cooperation with Huaxin Biotechnology in the future.

Chairman Li Lelin said: Huaxin Biotech attaches great importance to this negotiation. Wanze Pharmaceutical is a drug research and development and production enterprise. The Shenji ointment product has a good effect. Huaxin Bio has advanced equipment and biological efficacy. With the mature research and development technology of skin care products, we will highly combine the functional ingredients of ginseng ointment with skin care products. This will be another "weapon" to open up market segments. The two parties will establish a continuous and stable relationship in future cooperation. , Seek mutual benefit and seek long-term development together!